Radiofrequency coblation for treatment of advanced laryngotracheal recurrent respiratory papillomatosis

被引:28
作者
Carney, A. S. [1 ]
Evans, A. S.
Mirza, S.
Psaltis, A.
机构
[1] Flinders Med Ctr, ENT Unit, Dept Otolaryngol Head & Neck Surg, Adelaide, SA 5042, Australia
关键词
Radiofrequency; Coblation; Recurrent Respiratory Papillomatosis; Larynx; Trachea; POSTOPERATIVE PAIN; CHILDREN; TONSILLECTOMY; MICRODEBRIDER; CIDOFOVIR; THERAPY; LASER;
D O I
10.1017/S0022215109992398
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: A variety of treatment modalities are currently used to treat recurrent respiratory papillomatosis. We aimed to study the efficacy of radiofrequency cold ablation (coblation) for the treatment of laryngotracheal recurrent respiratory papillomatosis, by comparing treatment intervals for coblation and CO(2) laser vaporisation. Method: Retrospective case series of adult patients with advanced laryngotracheal recurrent respiratory papillomatosis. Results: Six patients were treated for at least two years by CO, laser vaporisation with or without intralesional cidofovir. All six subsequently underwent treatment with radiofrequency coblation with or without intralesional cidofovir. Coblation resulted in longer periods between interventions, compared with CO(2) laser (p = 0.03). Conclusion: Radiofrequency coblation appears to be an attractive alternative technique to CO, laser for the surgical treatment of advanced laryngotracheal papillomata.
引用
收藏
页码:510 / 514
页数:5
相关论文
共 50 条
  • [31] Systemic bevacizumab for treatment of recurrent respiratory papillomatosis
    Xiaoyun Zhao
    Jiajia Wang
    Qi Chen
    Xiufa Wu
    Wenjing Mao
    Jingru Ma
    Rui Fang
    Peijie He
    Chunsheng Wei
    [J]. European Archives of Oto-Rhino-Laryngology, 2024, 281 : 1865 - 1875
  • [32] Cimetidine for recurrent respiratory papillomatosis in pregnancy as an alternative adjuvant treatment
    Tan, Sien Hui
    Ghauth, Sakina
    Liew, Yew Toong
    Abu Bakar, Zulkiflee
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, 281 (02) : 1053 - 1055
  • [33] Systemic bevacizumab for treatment of recurrent respiratory papillomatosis
    Zhao, Xiaoyun
    Wang, Jiajia
    Chen, Qi
    Wu, Xiufa
    Mao, Wenjing
    Ma, Jingru
    Fang, Rui
    He, Peijie
    Wei, Chunsheng
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, 281 (04) : 1865 - 1875
  • [34] Safety and Dosing of Bevacizumab (Avastin) for the Treatment of Recurrent Respiratory Papillomatosis
    Best, Simon R.
    Friedman, Aaron D.
    Landau-Zemer, Tali
    Barbu, Anca M.
    Burns, James A.
    Freeman, Mason W.
    Halvorsen, Yuan-Di
    Hillman, Robert E.
    Zeitels, Steven M.
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2012, 121 (09) : 587 - 593
  • [35] Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients
    Carvalho, Christine Martins
    Huot, Laure
    Charlois, Anne-Laure
    Khalfallah, Sonia Ayari
    Chapuis, Francois
    Froehlich, Patrick
    [J]. ACTA OTO-LARYNGOLOGICA, 2009, 129 (04) : 462 - 470
  • [36] Recurrent respiratory papillomatosis
    Shykhon, M
    Kuo, M
    Pearman, K
    [J]. CLINICAL OTOLARYNGOLOGY, 2002, 27 (04): : 237 - 243
  • [37] Recurrent Respiratory Papillomatosis
    Ryan Ruiz
    Karen B. Zur
    [J]. Current Otorhinolaryngology Reports, 2021, 9 : 23 - 28
  • [38] Use of cidofovir in HPV patients with recurrent respiratory papillomatosis
    Grasso, M.
    Remacle, M.
    Bachy, V.
    Van Der Vorst, S.
    Lawson, G.
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2014, 271 (11) : 2983 - 2990
  • [39] Risk factors associated with severe recurrent respiratory papillomatosis
    Khan, Muddaseer
    Naidu, Tesuven K.
    [J]. SOUTHERN AFRICAN JOURNAL OF INFECTIOUS DISEASES, 2019, 34 (01)
  • [40] Use of cidofovir in HPV patients with recurrent respiratory papillomatosis
    M. Grasso
    M. Remacle
    V. Bachy
    S. Van Der Vorst
    G. Lawson
    [J]. European Archives of Oto-Rhino-Laryngology, 2014, 271 : 2983 - 2990